Hematology

Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials

Toca 5 Phase 3 trial results presented at the Society for Neuro-Oncology annual meeting

Duke launches center to explore innovative science and technology policy

Taiho Oncology reports promising findings for patients with prior gastrectomy

Phase 2 trial evaluates a new tool in pediatric cancer immunotherapy

Ivy Brain Tumor Center and Salarius conduct preclinical study to test seclidemstat

Expedeon signs deal with Abcam to sell off its immunology and proteomics businesses

ORYX announces positive Phase 1/2a data for oncolytic virus ParvOryx in metastatic, inoperable pancreatic cancer


Scientists develop drug-resistant cell line for lymphoma to better model disease development and drug reactions

Pluristem and the Department of Defense present positive PLX-R18 data

Illumina, QIAGEN ink 15-year agreement to expand options for in-vitro diagnostics

AIVITA Biomedical publishes article with data suggesting sPD-1 served as a predictive biomarker in Phase 2 melanoma trials